PLoS ONE · 2013 · 24 citations · 45 references
Life SciencesCell BiologyMolecular BiologyCell AdhesionHost-pathogen InteractionsMicrobial PathogenesisActin FilamentsBacterial PathogenesisBacterial Secretion SystemsBacterial ToxinsPathogen AdhesionToxin-mediated PathogenesisEscherichia ColiMacropinocytosis RegulationShiga ToxinsToxin InternalizationToxin Secretion MechanismsToxin Secretion SystemsToxin UptakeToxin-host Cell Interactions
Life-threatening intestinal and systemic effects of the Shiga toxins produced by enterohemorrhagic Escherichia coli (EHEC) require toxin uptake and transcytosis across intestinal epithelial cells. We have recently demonstrated that EHEC infection of intestinal epithelial cells stimulates toxin macropinocytosis, an actin-dependent endocytic pathway. Host actin rearrangement necessary for EHEC attachment to enterocytes is mediated by the type 3 secretion system which functions as a molecular syringe to translocate bacterial effector proteins directly into host cells. Actin-dependent EHEC attachment also requires the outer membrane protein intimin, a major EHEC adhesin. Here, we investigate the role of type 3 secretion in actin turnover occurring during toxin macropinocytosis. Toxin macropinocytosis is independent of EHEC type 3 secretion and intimin attachment. EHEC soluble factors are sufficient to stimulate macropinocytosis and deliver toxin into enterocytes in vitro and in vivo; intact bacteria are not required. Intimin-negative enteroaggregative Escherichia coli (EAEC) O104:H4 robustly stimulate Shiga toxin macropinocytosis into intestinal epithelial cells. The apical macropinosomes formed in intestinal epithelial cells move through the cells and release their cargo at these cells' basolateral sides. Further analysis of EHEC secreted proteins shows that a serine protease EspP alone is able to stimulate host actin remodeling and toxin macropinocytosis. The observation that soluble factors, possibly serine proteases including EspP, from each of two genetically distinct toxin-producing strains, can stimulate Shiga toxin macropinocytosis and transcellular transcytosis alters current ideas concerning mechanisms whereby Shiga toxin interacts with human enterocytes. Mechanisms important for this macropinocytic pathway could suggest new potential therapeutic targets for Shiga toxin-induced disease.
45
A global double‐fluorescent Cre reporter mouse
Mandar D. Muzumdar, Bosiljka Tasic, Kazunari Miyamichi et al. · genesis · 2007 · 3.7K citations · Full text
Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II Inhibitor
Aaron F. Straight, Amy Cheung, John Limouze et al. · Science · 2003 · 1.4K citations
Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
Pavel I. Kitov, Joanna Sadowska, George L. Mulvey et al. · Nature · 2000 · 864 citations
Joel A. Swanson, Colin Watts · Trends in Cell Biology · 1995 · 735 citations